TENAX THERAPEUTICS INC (TENX) Stock Analyst Ratings
USA - NASDAQ:TENX - US88032L6056 - Common Stock
6.99 USD
-0.05 (-0.71%)
ChartMill assigns a Buy % Consensus number of 87% to TENX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.42. This target is 206.44% above the current price.
TENX was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about TENX.
In the previous month the buy percentage consensus was at a similar level.
TENX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-08 | Piper Sandler | Initiate | Overweight |
| 2025-08-14 | Guggenheim | Maintains | Buy -> Buy |
| 2024-10-24 | Leerink Partners | Initiate | Outperform |
| 2024-10-14 | Guggenheim | Initiate | Buy |
| 2024-09-30 | William Blair | Initiate | Outperform |
| 2024-02-20 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-11-13 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-03-07 | Roth MKM | Initiate | Buy |
TENAX THERAPEUTICS INC / TENX FAQ
What is the average price target for TENAX THERAPEUTICS INC (TENX) stock?
11 analysts have analysed TENX and the average price target is 21.42 USD. This implies a price increase of 206.44% is expected in the next year compared to the current price of 6.99.
Can you provide the consensus rating for TENAX THERAPEUTICS INC stock?
The consensus rating for TENAX THERAPEUTICS INC (TENX) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.